Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma

Overview of attention for article published in Journal of Otolaryngology - Head & Neck Surgery, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 5,585 followers.

RT @ENT_Canada: Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchron…

07 Aug 2022

Reply Repost Favourite

RT @ENT_Canada: Pembrolizumab has been used in head and neck cancer immunotherapy for recurrence or metastatic disease with good success. T…

07 Aug 2022

Reply Repost Favourite

Pembrolizumab has been used in head and neck cancer immunotherapy for recurrence or metastatic disease with good success. This case report explores its use in early stage laryngeal cancer. https://t.co/n3lWa28LZ3

07 Aug 2022

Reply Repost Favourite

Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma https://t.co/yJVwi4M36N

22 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.